Challenges and best practices for hepatitis C care among people who inject drugs in resource limited settings
Focus group discussions with healthcare providers in Kenya
Bibliographic Data
| ID | 15540558 |
|---|---|
| Authors | Rie Seu (0000-0001-5116-6113, Montefiore Medical Center), Lindsey R Riback (0000-0001-8805-270X, Albert Einstein College of Medicine), Mercy Nyakowa (Ministry of Health), John Lizcano (0000-0003-4470-2189, Yale University), Helgar Musyoki (0000-0002-0972-6065, Ministry of Health), Jonathan Ross (0000-0002-4193-6919, Albert Einstein College of Medicine), Peter Cherutich (0000-0002-0019-0372, Ministry of Health), Ann Kurth (0000-0003-2300-6723, Yale University), Matthew J Akiyama (0000-0003-4290-3083, Montefiore Medical Center, corresponding author) |
| Year | 2022 |
| Volume | 17 |
| Issue | 12 |
| Pages | 3627-3637 |
| Publication date | 2022-08-08 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Global Public Health (JOURNAL) |
| Journal identifiers | ISSN: 1744-1692 • E-ISSN: 1744-1706 |
| Publisher | Taylor & Francis (PUBLISHER • GB) |
| DOI | 10.1080/17441692.2022.2110919 |
| PMID | 35941717 |
| OpenAlex | W4292451979 |
| Language | EN |
| Citations received | 1 |
| References cited | 35 |
People who inject drugs (PWID) living with Hepatitis C (HCV) in low- and middle-income countries face substantial barriers to HCV care. We sought to gain healthcare providers' perspectives on challenges and best practices for HCV care provision among PWID in Kenya. We conducted three focus group discussions (FGD) with 23 healthcare providers working with PWID living with HCV in Nairobi and Mombasa. Transcribed interviews were analysed thematically. Overarching themes regarding HCV prevention and treatment were: (1) lack of HCV-related knowledge at the provider and patient levels; (2) stigmatisation of people living with HCV and PWID; and (3) difficulties among PWID with navigating the healthcare system. Some providers suggested systematically integrating HCV care into existing PWID-specific harm reduction programs to improve HCV care provision as well as creating national HCV guidelines to guide clinicians. This study highlights the need for national HCV treatment guidelines and increased public HCV education, as well as culturally sensitive models integrating HCV care into programs PWID are already accessing. These strategies will be useful in improving access to HCV care among PWID and has the potential to decrease HCV transmission and prevalence among this vulnerable population
Economic growth · Environmental health · Family medicine · Focus group · Harm reduction · Health care · Hepatitis C · Population · Public health · Sociology · Hepatitis B Virus Studies · Hepatitis C virus research · HIV, Drug Use, Sexual Risk · Medicine · Nursing · Virology
Global epidemiology of hepatitis B and hepatitis C in people who inject drugs
Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs
An Ecological Perspective on Health Promotion Programs
Null
Barriers and facilitators of access to HIV, harm reduction and sexual and reproductive health services by women who inject drugs
Hepatitis C-related knowledge, attitudes and perceived risk behaviours among people who inject drugs in Kenya
Doing battle with “the monster”
Patient and provider perceived barriers and facilitators to direct acting antiviral hepatitis C treatment among priority populations in high income countries
The hepatitis C care cascade among people who inject drugs accessing harm reduction services in Catalonia
| Citations per year | 0.33 |
|---|---|
| Citation span | 2023 - 2023 (1) |
| Highly cited | No |